Evogene Ltd.
NASDAQ:EVGN
Overview | Financials
| Company Name | Evogene Ltd. |
| Symbol | EVGN |
| Currency | USD |
| Price | 1.27 |
| Market Cap | 11,067,072 |
| Dividend Yield | 0% |
| 52-week-range | 0.95 - 3.32 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Mr. Ofer Haviv CPA |
| Website | https://www.evogene.com |
An error occurred while fetching data.
About Evogene Ltd.
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD





